Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,5,1.06 [1.03-1.1],0.000497085209076684,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.11 [1.04-1.19],0.00100126469844345,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,8,1.05 [1.02-1.08],0.00240574592599129,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1.08 [1.02-1.14],0.00516592810150667,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,1.08 [1.02-1.14],0.00533170605903213,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,50,1.06 [1.01-1.12],0.0204692164420513,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.03 [1-1.06],0.0210369075170172,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,12,1.05 [1.01-1.1],0.0216625268203367,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.05 [1.01-1.09],0.0216827171681259,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1.27 [1.03-1.57],0.0280161342327291,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.02 [1-1.04],0.0525549581373744,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,1.03 [1-1.06],0.061056793597015,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1.03 [1-1.06],0.0661710077091485,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,3,1.05 [1-1.11],0.0682933790700408,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,5,1.05 [0.99-1.11],0.0935703915187121,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.15 [0.98-1.35],0.0954096999901236,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,1.16 [0.97-1.39],0.0985526695217623,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,1.06 [0.99-1.13],0.117208689096606,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.03 [0.99-1.06],0.119834550546436,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,1.14 [0.96-1.36],0.14199628901829,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,1.3 [0.91-1.86],0.143342541130807,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1.04 [0.99-1.09],0.146564544685134,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,0.97 [0.92-1.01],0.153583184784099,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,51,1.04 [0.99-1.09],0.157327667338144,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,9,1.1 [0.96-1.27],0.163979510383547,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.95 [0.89-1.02],0.174787963485769,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,27,1.05 [0.98-1.12],0.18812831385553,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.86 [0.66-1.11],0.241424634673977,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Wald ratio,1,0.9 [0.74-1.09],0.272393941276466,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,1.11 [0.92-1.34],0.280732795304413,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,1.02 [0.99-1.04],0.28296279743272,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,0.99 [0.97-1.01],0.311313373983295,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,5,0.95 [0.85-1.06],0.332865710509644,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,1.05 [0.95-1.17],0.337383161345081,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,1.06 [0.93-1.21],0.402147726005088,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Wald ratio,1,1.04 [0.95-1.13],0.412258898737096,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.06 [0.91-1.24],0.432361391721702,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_PANCOTH,Wald ratio,1,1.03 [0.95-1.13],0.437070344269525,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.96 [0.86-1.07],0.446963425343497,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,0.89 [0.67-1.19],0.450371261465045,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,1.07 [0.89-1.29],0.451123278564679,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.93 [0.76-1.13],0.45300935532918,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.91 [0.69-1.19],0.484484810120934,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,16,0.96 [0.86-1.08],0.486545594656051,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,21,1.02 [0.97-1.07],0.507870787299424,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,4,1.02 [0.96-1.09],0.512081952064799,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,G6_NERPLEX,Inverse variance weighted,4,1.05 [0.91-1.22],0.512410297087842,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1.04 [0.92-1.18],0.517185766550994,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,1.09 [0.84-1.42],0.526133539354946,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,0.98 [0.93-1.04],0.527672680799383,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Wald ratio,1,0.99 [0.94-1.03],0.574441508466585,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,1.04 [0.9-1.2],0.579207175842705,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,0.97 [0.88-1.08],0.595947598792991,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,0.99 [0.94-1.03],0.595953718072848,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.03 [0.91-1.18],0.638398047570099,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.02 [0.93-1.12],0.657369420945733,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,0.97 [0.82-1.14],0.676664809135843,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,0.99 [0.92-1.06],0.678373623185754,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.03 [0.9-1.17],0.690697932949599,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,1.02 [0.93-1.11],0.690697932949599,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,0.98 [0.89-1.08],0.711209304999308,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1.01 [0.97-1.04],0.71670344567571,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,25,1.02 [0.93-1.1],0.71679292508846,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.98 [0.87-1.1],0.730210426041389,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,12,1.01 [0.95-1.07],0.750286787847278,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,0.99 [0.9-1.08],0.783457056649009,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,1.03 [0.81-1.31],0.80069004832916,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,59,1.01 [0.96-1.05],0.801996260310189,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_POLY,Wald ratio,1,0.99 [0.89-1.1],0.812216230215303,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,1.02 [0.83-1.25],0.87656942627714,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.99 [0.93-1.06],0.878056865676923,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,24,1 [0.95-1.07],0.88192454529704,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_PSORIARTH,Inverse variance weighted,9,1 [0.97-1.02],0.890089037540456,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,3,1 [0.89-1.13],0.959938335148638,trans
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,5,1 [0.96-1.04],0.972736586137045,trans
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,3,1 [0.89-1.13],0.992256150472484,trans
